Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Vancomycin Population Pharmacokinetics and Exposure Variability in Children with Multiple Organ Dysfunction Syndrome

The model provides a foundation for prospective evaluation of individualized exposure estimation using sparse VAMS sampling and demonstrates substantial interindividual exposure variability despite population-based dosing.

M. Scheetz, Justin Shiau, Victor Amajor et al. · 0 citations
Open access Oct 2026

Development and validation of a cefepime population pharmacokinetic model to guide treatment for patients with hospital-acquired pneumonia requiring renal replacement

ABSTRACT Cefepime is used in critically ill pneumonia patients, but dosing in renal replacement therapy (RRT) is complicated by altered renal function, extracorporeal removal, and variability in pulmonary epithelial lining fluid (ELF) exposure. We sought to develop an integrated model linking systemic, extracorporeal,...

A. Valadez, Emma Harlan, M. Scheetz et al. · 0 citations
Open access Sep 2026

L2 β-lactamase contributes to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa

ABSTRACT The prevalence of non-susceptibility to ceftolozane-tazobactam (C/T) among Pseudomonas aeruginosa remains low, but novel mechanisms of C/T resistance are of concern. Herein, we describe a novel P. aeruginosa genotype associated with high-level C/T resistance (>256/4 µg/mL) in a single patient. Whole-genome seq...

Preeti Garai, Sophia H. Nozick, Caroline C. Jozefczyk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.